MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.The chemical structure of MDAI is indirectly derived from that of the illicit drug MDA, but the alpha-methyl group of the alkyl amino amphetamine side chain has been bound back to the benzene nucleus to form an indane ring system, which changes its pharmacological properties substantially.
5,6-Methylenedioxy-2-aminoindane (MDAI). MDAI is a new psychoactive substance (NPS) that
has structural similarities to MDA and MDMA and shares some of
their behavioural properties.
Chemical name: 5,6 methylenedioxy-2-aminoindane.
Street/brand names: Sparkle, Mindy, MDAI Gold.